Hyperaldosteronism - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Hyperaldosteronism – Complete Patient Guide

Hyperaldosteronism: A Comprehensive Patient Guide

Overview

Hyperaldosteronism, also called primary aldosteronism, is a hormonal disorder in which the adrenal glands produce too much aldosterone, a hormone that regulates sodium and potassium balance and blood‑pressure control. Excess aldosterone causes the kidneys to retain sodium (and water) while excreting potassium, leading to hypertension (high blood pressure) and electrolyte disturbances.

Who it affects: It can occur at any age, but most patients are diagnosed between 30 and 60 years old. Women are slightly more often affected than men (roughly 55 % vs. 45 %).

Prevalence: Historically considered rare, recent screening studies suggest that up to 5–10 % of patients with resistant hypertension have primary aldosteronism, translating to an estimated 2–3 million adults in the United States alone (CDC, 2022).

Symptoms

Many patients are asymptomatic aside from high blood pressure, which is why routine screening is important. When symptoms do appear, they are usually related to sodium retention, potassium loss, or the downstream effects of high blood pressure.

  • High blood pressure (hypertension): Often resistant to standard medications; may be discovered during routine checks.
  • Headaches: Persistent throbbing headaches, especially in the morning.
  • Dizziness or light‑headedness: Can result from blood‑pressure spikes or electrolyte imbalance.
  • Muscle weakness or cramps: Low potassium (hypokalemia) interferes with muscle function.
  • Fatigue: Chronic low‑energy state caused by electrolyte disturbances.
  • Frequent urination (polyuria) and nocturia: Sodium‑induced fluid retention can alter renal concentrating ability.
  • Heart palpitations or arrhythmias: Low potassium can provoke irregular heart rhythms.
  • Tingling or numbness (paresthesia): Often felt in the hands and feet; another sign of hypokalemia.
  • Excess thirst: Related to fluid shifts from sodium retention.

Note: Some patients present only with high blood pressure and no other overt symptoms, emphasizing the need for targeted testing in resistant cases.

Causes and Risk Factors

Primary (idiopathic) hyperaldosteronism

  • Adrenal adenoma (Conn’s tumor): A benign, single‑gland tumor that autonomously secretes aldosterone (~30–40 % of cases).
  • Bilateral adrenal hyperplasia: Diffuse enlargement of both adrenal glands; accounts for ~60 % of cases.

Secondary hyperaldosteronism

Caused by external stimuli that increase renin → aldosterone pathway:

  • Renal artery stenosis or chronic kidney disease.
  • Heart failure, cirrhosis, or nephrotic syndrome (low effective circulating volume).
  • Medications: diuretics, ACE inhibitors, ARBs, or NSAIDs that stimulate renin production.

Risk factors

  • Family history of hypertension or known adrenal adenoma.
  • African‑American ethnicity (higher prevalence of hypertension, which can mask underlying aldosterone excess).
  • Obesity and metabolic syndrome – associated with increased adrenal activity.
  • Long‑standing resistant hypertension (BP ≥ 140/90 mmHg on three or more antihypertensives, including a diuretic).

Diagnosis

Because the condition is often hidden, a stepwise diagnostic algorithm is recommended (Mayo Clinic, 2023). The process includes screening, confirmatory testing, and subtyping.

1. Screening Tests

  • Plasma aldosterone concentration (PAC) and plasma renin activity (PRA) ratio: A PAC ≥ 15 ng/dL with a PRA ≤ 1 ng/mL/h, giving a ratio >20, is considered a positive screen. Some labs use ARR > 30 when aldosterone is measured in ng/dL and renin in mU/L.
  • 24‑hour urine aldosterone: Helpful when plasma measurements are unreliable (e.g., due to medication effects).
  • Screening should be performed after correcting hypokalemia, withholding interfering meds (e.g., spironolactone, amiloride, eplerenone) for 2–4 weeks, and keeping the patient upright for at least 2 hours.

2. Confirmatory Tests

If the screen is positive, at least one confirmatory test is required:

  • Saline infusion test: 2 L of isotonic saline infused over 4 h; aldosterone should suppress <10 ng/dL. Failure to suppress confirms autonomous secretion.
  • Captopril challenge test: 25–50 mg oral captopril; aldosterone should fall >30 % in normal physiology.
  • Fludrocortisone suppression test: More sensitive but labor‑intensive; reserved for equivocal cases.

3. Subtype Imaging & Lateralization

  • Adrenal CT scan: Detects adenomas >1 cm; however, incidental non‑functioning nodules are common.
  • Adrenal vein sampling (AVS): Gold standard to differentiate unilateral adenoma from bilateral hyperplasia. Performed by an interventional radiologist; compares aldosterone levels from each adrenal vein after cosyntropin stimulation.

4. Additional Laboratory Evaluation

  • Serum electrolytes (focus on potassium < 3.5 mmol/L).
  • Renal function (creatinine, eGFR) – both for baseline and medication safety.
  • Blood glucose and lipid profile – because hypertension often coexists with metabolic disease.

Treatment Options

Treatment is individualized based on the underlying cause and patient comorbidities.

1. Surgical Management

  • Adrenalectomy (laparoscopic or robotic): First‑line for unilateral aldosterone‑producing adenomas. Post‑operative cure rates of hypertension range from 30–60 % and normalize potassium in >90 % of patients (Cleveland Clinic, 2022).
  • Pre‑operative preparation includes correcting hypokalemia and stopping potassium‑sparing diuretics.

2. Medical Management

  • Mineralocorticoid receptor antagonists (MRAs):
    • Spironolactone: 25–100 mg daily; inexpensive, but can cause gynecomastia and menstrual irregularities.
    • Eplerenone: 25–100 mg daily; more selective with fewer hormonal side effects, but higher cost.
    Goal: normalize serum potassium and lower blood pressure.
  • Adjunct antihypertensives: Calcium‑channel blockers or β‑blockers may be added if blood pressure remains elevated after MRA therapy.
  • Potassium supplementation: Oral potassium chloride as needed; monitor serum levels regularly.

3. Lifestyle & Dietary Changes

  • Low‑sodium diet: < 2 g (≈ 85 mmol) of sodium per day reduces fluid retention and eases blood‑pressure control.
  • Potassium‑rich foods: Bananas, oranges, potatoes, spinach—help counteract aldosterone‑induced loss (unless contraindicated by renal disease).
  • Weight management and regular aerobic exercise: Improves overall cardiovascular health and may reduce medication requirements.

Living with Hyperaldosteronism

Medication adherence

Take MRAs exactly as prescribed. Skipping doses can cause a rapid rise in blood pressure and potassium loss. Set daily alarms or use a pill‑box.

Regular monitoring

  • Blood pressure: Check at home ≥ 2 times per week; keep a log.
  • Serum potassium and creatinine: Baseline, then every 1–3 months while adjusting therapy.
  • Follow‑up visits: Typically every 3–6 months with your endocrinologist or hypertension specialist.

Dietary tips

  • Read nutrition labels – aim for <5 g of sodium per serving.
  • Use herbs, garlic, lemon, or vinegar for flavor instead of salt.
  • Limit processed foods, canned soups, and fast‑food meals which are high in sodium.

Exercise and stress management

Moderate‑intensity activities (brisk walking, cycling, swimming) for at least 150 minutes per week are recommended by the American Heart Association. Stress‑reduction techniques such as deep breathing, yoga, or meditation can help keep blood pressure stable.

When to contact your healthcare team

  • Persistent dizziness, muscle weakness, or heart palpitations.
  • New or worsening headache despite medication.
  • Any lab result indicating potassium < 3.0 mmol/L or a sudden rise in creatinine.
  • Side effects from medication (e.g., breast tenderness from spironolactone).

Prevention

Because primary hyperaldosteronism is largely idiopathic, true primary prevention is not possible. However, secondary hyperaldosteronism can often be mitigated:

  • Control blood pressure early with lifestyle measures to avoid resistant hypertension.
  • Manage chronic kidney disease, heart failure, and liver cirrhosis according to guideline‑directed therapy.
  • Avoid chronic high‑dose diuretic use without monitoring renin‑aldosterone status.
  • Maintain a healthy weight and limit alcohol intake, which can exacerbate adrenal overactivity.

Complications

If left untreated, excess aldosterone can cause serious, sometimes irreversible damage:

  • Cardiovascular disease: Left‑ventricular hypertrophy, congestive heart failure, myocardial infarction, and stroke—risk is 2–3 times higher than in essential hypertension alone (NIH, 2021).
  • Kidney damage: Progressive chronic kidney disease due to long‑standing hypertension and sodium‑induced glomerular injury.
  • Electrolyte‑related arrhythmias: Severe hypokalemia can precipitate ventricular tachycardia or sudden cardiac death.
  • Metabolic alkalosis: Loss of hydrogen ions with aldosterone excess may cause persistent alkalosis, leading to fatigue and respiratory compensation.
  • Reduced quality of life: Chronic headaches, fatigue, and medication side effects can impair daily functioning.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience any of the following:

  • Severe, sudden headache with vision changes or confusion.
  • Chest pain or pressure radiating to the arm, jaw, or back.
  • Palpitations accompanied by fainting, dizziness, or shortness of breath.
  • Muscle weakness or cramping with a known potassium level < 2.5 mmol/L.
  • Rapid, irregular heartbeat (pulse > 120 bpm) or feeling of skipped beats.

These signs may indicate a hypertensive crisis, life‑threatening arrhythmia, or severe electrolyte disturbance that requires immediate treatment.

References

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References